The webinar will feature presentations from Key Opinion Leaders (KOL’s) Amaal J. Starling, M.D. (Mayo Clinic College of Medicine and…
Join us for the Cantargia R&D Day, featuring presentations from two renowned oncology experts. Prof Eric Van Cutsem, MD, PhD (University Hospitals…
The event will feature presentations from Key Opinion Leaders (KOL’s) Sarah Sammons, MD (Duke University) and Senthil Damodaran, MD, PhD (MD Anderson…
The webinar will feature a presentation from Key Opinion Leader (KOL) Dr. Michael Savona, MD (Vanderbilt University School of Medicine) who will…
The webinar will feature a presentation from Frank A. Giordano, M.D. (Chair, Department of Radiation Oncology, University Hospital Bonn, Germany), who…
The analyst day will feature presentations from Amir London (Chief Executive Officer), Chaime Orlev (Chief Financial Officer), and Jon R. Knight (Vice President, U.S.…
Focus on NuVasive’s strategic growth plan, including the Company’s less invasive spine product portfolio, new product introductions and globalization strategy…
The data call will feature Key Opinion Leaders (KOL’s) Brian Druker, M.D. (Oregon Health & Science University), Naval G. Daver, M.D.…
The webinar will feature presentations from Key Opinion Leaders (KOL’s) Anna Hemnes, MD (Vanderbilt University Medical Center), John Ryan, MD, MB,…

Join us for the Arrowhead Pulmonary R&D Day, featuring presentations from Key Opinion Leaders (KOLs) Mario Castro, M.D., MPH (University of…
FULLY VIRTUAL Wednesday, May 25, 2022 Presentations: 7:30 – 8:30 AM ET / 1:30 – 2:30 PM CEST Join us…
The webinar will feature a presentation from Key Opinion Leader (KOL) Christophe Martinaud, MD, PhD who will discuss the current treatment landscape…
TScan will provide a summary of the Company’s ASGCT posters and oral presentation as well as a discussion of TScan’s…
The webinar will feature presentations from Key Opinion Leaders (KOLs) Kelly E. Dunn, PhD, MBA (Johns Hopkins School of Medicine) and Stuart Gitlow,…
The Power of Targeted Protein Degradation (TPD) and How It Could Redefine the Hepatocellular Carcinoma (HCC) Treatment Paradigm Captor Therapeutics’…
The VYNE Therapeutics KOL Webinar will feature a presentation from Gerald V. Denis, PhD (Boston University School of Medicine) and Thierry…